CompletedPhase 3

Effects of Autologous Blood Injection Versus Platelet Rich Plasma on Chronic Plantar Fasciitis

Turkey (Türkiye)60 participantsStarted 2020-03-01

Plain-language summary

To explore effects of Autologous Blood Injection versus Platelet Rich plasma injection for treatment of chronic plantar fasciitis

Who can participate

Age range

40 Years – 65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Participants who were diagnosed with chronic plantar fasciitis
. Nonresponded to o conservative treatment (stretching exercises, nonsteroidal anti-inflammatory drugs, and heel pads) for at least 6 weeks
. Patient should be able to understand the informed consent about type of treatment and blindness and randomization
. Visual analog scale pain higher than 5 (on a 10-point visual analog scale)

Exclusion criteria

. previous history of any type of local injection treatment for heel pain
. history of surgery for heel pain, foot and ankle disorders, fractures
. Associated pathology involving the lower limb such as
. Patients with systemic disorder like diabetes mellitus, ankylosing spondylitis rheumatoid arthritis, hematological disease, or gout
. Pregnancy
. Use of antiocoagulation -

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Changes in Visual Analogue Scale (VAS)

Timeframe: 0,1 st 3rd and 6th month; changes between time points will be assessed

Changes in American Orthopaedic Foot & Ankle Society (AOFAS ) Score

Timeframe: 0,1 st 3rd and 6th month; changes between time points will be assessed

Changes in Foot and Ankle Disability Index (FADI)

Timeframe: 0,1 st 3rd and 6th month; changes between time points will be assessed

Trial details

NCT IDNCT05240872

SponsorIstanbul Training and Research Hospital

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2020-10-30

View on ClinicalTrials.gov More Plantar Fascitis trials

Who can participate

Age range

40 Years – 65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Participants who were diagnosed with chronic plantar fasciitis
. Nonresponded to o conservative treatment (stretching exercises, nonsteroidal anti-inflammatory drugs, and heel pads) for at least 6 weeks
. Patient should be able to understand the informed consent about type of treatment and blindness and randomization
. Visual analog scale pain higher than 5 (on a 10-point visual analog scale)

Exclusion criteria

. previous history of any type of local injection treatment for heel pain
. history of surgery for heel pain, foot and ankle disorders, fractures
. Associated pathology involving the lower limb such as
. Patients with systemic disorder like diabetes mellitus, ankylosing spondylitis rheumatoid arthritis, hematological disease, or gout
. Pregnancy
. Use of antiocoagulation -

What they're measuring

Changes in Visual Analogue Scale (VAS)

Timeframe: 0,1 st 3rd and 6th month; changes between time points will be assessed

Changes in American Orthopaedic Foot & Ankle Society (AOFAS ) Score

Timeframe: 0,1 st 3rd and 6th month; changes between time points will be assessed

Changes in Foot and Ankle Disability Index (FADI)

Timeframe: 0,1 st 3rd and 6th month; changes between time points will be assessed